Anxiety Sensitivity Treatment for Heroin Users

NCT01196312 | Completed

• 1 other identifier: DA023384
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.

Conditions

Anxiety

Keywords

anxiety sensitivity; heroin

Outcome Measures

Primary Outcomes (1)

• Anxiety Sensitivity Index-3

  24 weeks

Secondary Outcomes (1)

• Timeline Follow Back 90 days

  24 weeks

Interventions

Anxiety sensitivity therapy BEHAVIORAL

ASTH consists of 6 sessions of individual treatment, each lasting approximately 75 minutes over 3 weeks. In general, each session consists of the following components1) psychoeducation regarding the anxiety response, with a focus on increasing awareness of the ways in which the patient interprets or evaluates that response 2) assistance in developing healthy emotion regulation strategies that can be used to increase acceptance and tolerance of the anxiety response (including associated catastrophic thoughts), as well as understanding the consequences associated with avoidance or control of anxiety 3) a minimum of 3 interoceptive exercises tailored to activate feared anxiety-related sensations and 4) daily homework assignments (i.e., daily anxiety monitoring and interoceptive exercises).

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• exhibit a score of 21 on a self-report measure of anxiety sensitivity
• be in 28 days of residential substance use treatment.
• meet criteria for current opioid dependence as determined by SCID interview administered at intake.

You may not qualify if:

• evidence of limited mental competency
• the inability to give informed, voluntary, written consent to participate
• current psychosis
• current bipolar disorder.

Sponsors & Collaborators

• University of Maryland, College Park: lead

Study Sites (1)

Salvation Army Harbor Light Treatment Facilitiy

Washington D.C., District of Columbia, 20002, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director - HRPP (C. Lejuez is no longer at UMD)

Study Record Dates

• First Submitted: August 23, 2010
• First Posted: September 8, 2010
• Study Start: October 1, 2009
• Primary Completion: March 1, 2011
• Study Completion: September 1, 2011
• Last Updated: May 30, 2023

Record last verified: 2023-05

Locations

US (1)